These insulin delivery findings with closed-loop system use are not unusual in young patients with T1D who may not be receiving sufficient insulin to reach appropriate glycemic control; as indicated by higher baseline hyperglycemia, glucose variability, and HbA1c levels. This evidence concerns the gene INS and Hyperglycemia.